ARK Innovation ETF vs Procter & Gamble Co — how do they compare? ARK Innovation ETF trades at $79.61, while Procter & Gamble Co trades at $147.55 (market cap $342.40B). The key difference: Procter & Gamble Co pays a 2.9% dividend while ARK Innovation ETF pays none, and ARK Innovation ETF is trading nearer its 52-week high, Procter & Gamble Co nearer its low. Which is the better fit depends on your goals.
| ARKK | PG | |
|---|---|---|
52-Week High | $92.50 | $167.18 |
52-Week Low | $63.52 | $138.10 |
Market Cap | — | $342.40B |
Volume | — | 6,423,436 |
Sector | — | Consumer Staples |
Enterprise Value | — | $367.88B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
ARK Innovation ETF (ARKK) trades at $80.25, down 1.58% today, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The ETF has gained about 2% year-to-date through late June, sitting near its pivot point of $81. Recent news highlights Cathie Wood's continued stock purchases during pullbacks while the fund faces criticism for its 0.75% expense ratio and underperformance relative to broader tech markets.
The outlook remains mixed with strong technical momentum but fundamental concerns about fees and concentrated exposure to volatile innovation stocks. Key risks include Tesla's 10% weighting creating single-stock vulnerability and the fund's history of 37.88% losses over five years despite recent investor interest resurgence.
Procter & Gamble (PG) trades at $147.04, up 0.13% on the day, with a bearish technical signal from moving averages but neutral oscillators. The stock is supported by strong fundamentals, including consistent earnings beats, a 19.16% net income margin, and a dividend track record with a recent $1.09 payout. Revenue growth remains modest, with 2025 revenue at $84.28B, while valuation ratios like a P/E of 21.5 reflect a premium to peers. Recent news highlights PG's supply chain enhancements and a new WNBA partnership, though some analysts question near-term upside due to soft demand.
The outlook for PG is cautiously optimistic, with a consensus price target of $159.75 implying potential upside. Strengths include stable cash flow and brand resilience, but risks involve premium valuation pressures and macroeconomic headwinds. Investors may find value in its dividend consistency and operational efficiency, though volatility from market sentiment warrants monitoring.
Trailing returns across standard periods
The fund will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund’s investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The fund is non-diversified.
Read more on ARKK →The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →